Paolo Di Mascio Selected Research

Paolo Di Mascio Research Topics

Disease

9	Neoplasms (Cancer) 01/2021 - 02/2002
8	Inflammation (Inflammations) 01/2021 - 07/2012
6	Photosensitivity Disorders (Photodermatitis) 01/2019 - 12/2002
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 02/2009
4	Carcinogenesis 11/2015 - 02/2002
3	Acute Intermittent Porphyria (Porphyria, Acute) 03/2005 - 02/2002
2	Cataract (Cataracts) 11/2020 - 01/2019
2	Skin Neoplasms (Skin Cancer) 01/2019 - 01/2014
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2013 - 05/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2008 - 08/2007
2	Lead Poisoning (Poisoning, Lead) 03/2005 - 01/2002
2	Hepatocellular Carcinoma (Hepatoma) 12/2004 - 02/2002
1	Communicable Diseases (Infectious Diseases) 11/2021
1	Infections 11/2021
1	COVID-19 11/2021
1	Arthritis (Polyarthritis) 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Hyperuricemia 12/2017
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2017
1	Myocardial Infarction 01/2016
1	Pain (Aches) 01/2016
1	Melanoma (Melanoma, Malignant) 05/2012
1	Colonic Neoplasms (Colon Cancer) 07/2011
1	Hemorrhage 07/2011
1	Alkalosis 09/2009
1	Acidosis 09/2009
1	Alzheimer Disease (Alzheimer's Disease) 08/2007
1	Atherosclerosis 08/2007
1	Porphyrias (Porphyria) 03/2005
1	Tyrosinemias (Tyrosinemia) 03/2005
1	Lung Neoplasms (Lung Cancer) 02/2004
1	Vascular Diseases (Vascular Disease) 09/2003
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 12/2002
1	Abdominal Pain (Pain, Abdominal) 02/2002

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2002
7	AldehydesIBA 01/2021 - 01/2002
6	Proteins (Proteins, Gene)FDA Link 11/2021 - 12/2002
4	Singlet OxygenIBA 01/2019 - 12/2002
4	Heme (Haem)IBA 03/2005 - 01/2002
4	AcidsIBA 03/2005 - 01/2002
3	Oxygen (Dioxygen)IBA 01/2019 - 11/2015
3	DNA AdductsIBA 01/2019 - 06/2011
3	LipidsIBA 01/2019 - 12/2002
3	AcetaldehydeIBA 01/2018 - 06/2011
3	Superoxide Dismutase-1IBA 10/2013 - 02/2009
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	MetalsIBA 01/2021 - 01/2002
2	Photosensitizing Agents (Photosensitizers)IBA 11/2020 - 01/2018
2	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2018 - 09/2003
2	N,N'- di(2,3- dihydroxypropyl)- 1,4- naphthalenedipropanamide 1,4-endoperoxideIBA 01/2018 - 09/2003
2	Melanins (Melanin)IBA 01/2014 - 05/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2012 - 01/2002
2	MelatoninIBA 06/2011 - 09/2003
2	Cytochromes c (Cytochrome c)IBA 09/2009 - 08/2007
1	HDL LipoproteinsIBA 11/2021
1	Apolipoproteins MIBA 11/2021
1	ProteomeIBA 11/2021
1	Crystallins (Crystallin)IBA 11/2020
1	tryptophyltryptophanIBA 11/2020
1	tyrosyltyrosine (Tyr-Tyr)IBA 11/2020
1	Peptides (Polypeptides)IBA 11/2020
1	tryptophyltyrosineIBA 11/2020
1	1,N(6)-ethenodeoxyadenosineIBA 01/2019
1	EnzymesIBA 01/2019
1	Nucleic AcidsIBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 01/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 10/2018
1	Rose BengalIBA 01/2018
1	Uric Acid (Urate)IBA 12/2017
1	NucleosidesIBA 11/2015
1	AminesIBA 05/2014
1	Methionine (L-Methionine)FDA Link 05/2014
1	tempolIBA 10/2013
1	Docosahexaenoic AcidsIBA 01/2013
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2013
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2012
1	InterleukinsIBA 07/2012
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 05/2012
1	Hemoglobins (Hemoglobin)IBA 07/2011
1	Lipid PeroxidesIBA 07/2011
1	beta Carotene (Betacarotene)FDA Link 02/2004
1	Lipoproteins (Lipoprotein)IBA 09/2003
1	Indicators and Reagents (Reagents)IBA 09/2003
1	NitrogenIBA 09/2003
1	PorphyrinsIBA 02/2002
1	4,5-dioxovaleric acidIBA 01/2002

Therapy/Procedure

3	Photochemotherapy (Photodynamic Therapy) 05/2012 - 02/2002
1	Lenses 11/2020
1	Glycemic Control 12/2017